TNFRSF1B and neoplasm: Previous studies showed that TNFR2+ Tregs increased in tumors of cervical cancer patients, and Foxp3+ tumor infiltrating immune cells in the central tumor area might be a biomarker for risk stratification in cervical cancer patients [17–19].